Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Jazz Pharmaceuticals plc - Ordinary Shares
(NQ:
JAZZ
)
226.55
-6.09 (-2.62%)
Streaming Delayed Price
Updated: 1:14 PM EDT, Jun 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
654,225
Open
231.91
Bid (Size)
226.44 (100)
Ask (Size)
226.65 (300)
Prev. Close
232.64
Today's Range
224.23 - 232.69
52wk Range
105.00 - 243.32
Shares Outstanding
62,311,104
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
↗
May 30, 2026
Ultragenyx develops therapies for rare genetic diseases, with a portfolio spanning approved biologics and a pipeline of gene therapies.
Via
The Motley Fool
Topics
Regulatory Compliance
3 Healthcare Stocks We Think Twice About
May 29, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Via
StockStory
Performance
YTD
+30.8%
+30.8%
1 Month
+8.9%
+8.9%
3 Month
+18.9%
+18.9%
6 Month
+31.6%
+31.6%
1 Year
+109.2%
+109.2%
More News
Read More
3 Mid-Cap Stocks We’re Skeptical Of
May 25, 2026
Via
StockStory
Is Marriott Stock a Buy After GMT Capital Initiated a Position Worth Over $66 Million?
↗
May 20, 2026
Via
The Motley Fool
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surges 3.7% After-Hours on Q1 2026 Revenue and EPS Beat
↗
May 05, 2026
Via
Chartmill
Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 12, 2026
Via
StockStory
Topics
Earnings
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
May 06, 2026
Via
StockStory
JAZZ Q1 Deep Dive: Oncology and Neuroscience Drive Double-Digit Revenue Growth, Eyes on Upcoming Approvals
May 06, 2026
Via
StockStory
Jazz (JAZZ) Q1 2026 Earnings Call Transcript
↗
May 05, 2026
Via
The Motley Fool
Topics
Earnings
JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) Beats Q4 Estimates but 2026 Guidance Tempers Gains
↗
February 24, 2026
Via
Chartmill
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales
May 05, 2026
Via
StockStory
Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For
May 03, 2026
Via
StockStory
Topics
Artificial Intelligence
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
April 26, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Overrated Stocks with Warning Signs
April 23, 2026
Via
StockStory
3 Reasons to Sell JAZZ and 1 Stock to Buy Instead
April 21, 2026
Via
StockStory
Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
April 06, 2026
Via
MarketMinute
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
March 31, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
1 Value Stock to Research Further and 2 We Ignore
March 18, 2026
Via
StockStory
3 Healthcare Stocks Walking a Fine Line
March 13, 2026
Via
StockStory
Zymeworks (ZYME) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
Via
The Motley Fool
Topics
Earnings
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
February 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Supply Chain
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales
February 24, 2026
Via
StockStory
Jazz Pharmaceuticals Earnings: What To Look For From JAZZ
February 22, 2026
Via
StockStory
Topics
Artificial Intelligence
Government
World Trade
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
February 15, 2026
Via
StockStory
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
February 10, 2026
Via
StockStory
Frequently Asked Questions
Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 226.55
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 06/02/26 01:14 PM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 14.12B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 14B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.